MolPort-001-740-041

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

18 API Suppliers, 10 USDMF, 7 CEP/COS, 9 NDC API, 8 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

248 Drugs in Development

248 Drugs in Development

FINISHED DOSAGE FORMULATIONS

322 FDF Dossiers, 177 FDA Orange Book, 113 Europe, 5 Canada, 10 Australia, 9 South Africa, 8 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 1MG, TABLET;ORAL - 2.5MG, TABLET;ORAL - 20MG, TABLET;ORAL - 50MG, TABLET;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 4 SPI Pharma, 2 DKSH, 5 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 5 Kirsch Pharma, 4 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 24 BASF, 1 CD Formulation, 7 DFE Pharma, 1 Finar, 10 Gangwal Chemicals, 1 Ideal Cures, 4 Ingredion Pharma Solutions, 16 Kerry, 3 Keval Exports, 14 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 21 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

50 Fillers, Diluents & Binders, 39 Disintegrants & Superdisintegrants, 36 Direct Compression, 32 Granulation, 23 Thickeners and Stabilizers, 21 Solubilizers, 18 Lubricants & Glidants, 15 Parenteral, 12 Film Formers & Plasticizers, 11 Coating Systems & Additives, 11 Co-Processed Excipients, 10 Taste Masking, 10 Chewable & Orodispersible Aids, 9 Topical, 9 Emulsifying Agents, 9 Controlled & Modified Release, 5 Surfactant & Foaming Agents, 3 Rheology Modifiers, 2 API Stability Enhancers